Viltepso Carves US DMD Position Despite Headwinds

 
• By Lisa Takagi
  
Viltepso has its US sales growing
VIltepso's US sales took off since 2020 launch after accelerated approval. (Shutterstock)

More from Gene Therapies

More from Advanced Therapies